Overview
Good Pharmacovigilance Practice (GVP) Training is an educational program designed to teach professionals the standards and requirements for monitoring the safety of pharmaceutical products throughout their lifecycle. This training ensures that pharmacovigilance personnel understand their responsibilities and can conduct safety monitoring in accordance with regulatory requirements. This guide explains what GVP training covers and who needs to complete it.
What Does GVP Training Cover?
GVP Training covers a wide range of topics essential for pharmacovigilance compliance, including:
- ICH E2 Series – E2A (Clinical Safety Data Management), E2B(R3) (ICSR Data Elements), E2C(R2) (Periodic Benefit-Risk Evaluation Report), E2D (Post-Approval Safety Data), E2E (Pharmacovigilance Planning), and E2F (Development Safety Update Report)
- EU GVP Modules – European Medicines Agency guidelines for pharmacovigilance systems
- FDA Regulations – 21 CFR Parts 312 and 314 for adverse event reporting
- Canadian GVP Guidelines – Health Canada requirements for drug safety monitoring
- MedDRA Coding – the international standard for coding adverse events
- Signal Detection and Risk Management – principles and practices
Training also covers specific operational areas such as adverse event case processing, safety data exchange agreements, and inspection readiness.
Who Needs GVP Training?
GVP Training is required for all personnel involved in pharmacovigilance-related activities. This includes:
- Pharmacovigilance and Drug Safety Professionals – responsible for safety monitoring
- Clinical Research Associates and Clinical Trial Monitors – involved in clinical trial safety
- Regulatory Affairs Specialists – managing safety submissions
- Quality Assurance Personnel – ensuring quality of pharmacovigilance systems
- Medical Affairs Professionals – involved in post-marketing safety
- Contract Research Organization (CRO) Staff – providing pharmacovigilance services
- Marketing Authorization Holders – responsible for drug safety obligations
Anyone who handles safety data, assesses adverse events, or manages risk minimization activities requires GVP training.
Detailed Course Breakdown
Course 1: Global Pharmacovigilance and Safety Reporting
This training program provides a comprehensive and detailed understanding of global regulatory requirements for pharmacovigilance, including adverse event reporting, signal detection, risk management, and periodic safety reporting.
Scope: The program integrates requirements from major regulatory bodies, including the FDA (21 CFR Parts 312 and 314), ICH guidelines (E2A, E2B(R3), E2C(R2), E2D(R1), E2E, E2F), EU GVP modules, Canadian GVP guidelines, and MedDRA coding standards.
Description of Modules: The curriculum covers 10 comprehensive sections:
- Introduction to Pharmacovigilance and its importance in drug safety
- Adverse Event Reporting – definitions and classifications
- Expedited Reporting – 7-day and 15-day reporting requirements
- Periodic Safety Reports – PSURs, PBRERs, and DSURs
- Signal Detection and risk management planning
- MedDRA Coding and Standardised MedDRA Queries (SMQs)
- Pharmacovigilance System establishment and maintenance
- Risk Management Plans and risk minimization measures
- Global Regulatory Requirements across jurisdictions
- Case Studies and practical application scenarios
Target Audience:
- Pharmacovigilance and Drug Safety Professionals
- Clinical Research Associates and Clinical Trial Monitors
- Regulatory Affairs Specialists
- Quality Assurance Personnel in Pharmaceutical Companies
- Medical Affairs Professionals
- Contract Research Organization (CRO) Staff
- Marketing Authorization Holders (MAHs) and their representatives
Pricing: $349.00 with group discounts available.
FAQ:
- What is the definition of GVP? GVP (Good Pharmacovigilance Practice) is the standard for monitoring drug safety throughout the product lifecycle.
- Who requires GVP training? Anyone involved in pharmacovigilance-related activities, including safety professionals, clinical research staff, and regulatory affairs personnel.
- What is the difference between GVP and GCP? GCP covers clinical trial conduct, while GVP covers post-approval drug safety monitoring.
- How often should GVP training be updated? Training should be updated annually to reflect regulatory changes and industry best practices.
- Is GVP training mandatory for all pharmaceutical professionals? GVP training is mandatory for personnel involved in drug safety monitoring and regulatory compliance.
Enroll Now: https://www.gxptrainings.com/courses/global-pharmacovigilance-and-safety-reporting/
Course 2: Certified Regulatory Affairs Professional (CRAP)
This comprehensive certification program provides regulatory professionals with end-to-end knowledge of the global pharmaceutical regulatory landscape, including critical pharmacovigilance requirements.
Scope: The program covers the complete drug development lifecycle from discovery through post-approval lifecycle management, with specific focus on the regulatory requirements of the FDA, EMA, and PMDA.
Description of Modules: The curriculum covers 10 comprehensive sections:
- Global Regulatory Framework overview
- Investigational New Drug (IND) applications
- New Drug Applications (NDA) for innovative pharmaceuticals
- Abbreviated New Drug Applications (ANDA) for generics
- Biologics License Applications (BLA) for biological products
- Orphan Drug Designation for rare disease treatments
- Special Programs including Accelerated Approval and Breakthrough Therapy
- Pharmacovigilance and Post-Marketing Requirements
- Regulatory Agency Interactions and meeting management
- Global Regulatory Strategy development
Target Audience:
- Regulatory Affairs Professionals
- Pharmacovigilance and Drug Safety Professionals
- Pharmaceutical Development and Formulation Scientists
- Quality Assurance/Quality Control Professionals
- Clinical and Nonclinical Development Professionals
- CMC Specialists and Manufacturing Personnel
- Project Management Professionals
- CRO and CMO Personnel
- Legal and Intellectual Property Professionals
Pricing: $799.00 with group discounts available.
FAQ:
- What is the role of GVP in the drug development lifecycle? GVP ensures ongoing safety monitoring from clinical trials through post-approval marketing.
- What is the difference between a risk management plan and a pharmacovigilance system? A risk management plan describes specific risk minimization measures, while a pharmacovigilance system is the overall framework for safety monitoring.
- What are the key elements of a pharmacovigilance system master file? The PSMF includes descriptions of processes, responsibilities, and documentation for the pharmacovigilance system.
- How does GVP training prepare me for pharmacovigilance roles? GVP training provides the knowledge and skills needed for drug safety monitoring, signal detection, and regulatory compliance.
- What is the difference between expedited and periodic reporting? Expedited reporting is for urgent safety concerns (7-day and 15-day reports), while periodic reporting includes regular safety summaries like PBRERs.
Enroll Now: https://www.gxptrainings.com/courses/certified-regulatory-affairs-professional/
Get Your Team Offer
For organizations looking to enroll multiple participants, we offer specialized team packages and volume discounts. Please reach out to our partnership team to discuss your specific needs and scores.
Contact Us: https://www.gxptrainings.com/contact-us/
Authors
